• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

36
13
11
5
5

COUNTRY

5
5
2
1
1

CATEGORIES

  • 135
  • 37
  • 29
  • 15
  • 13
  • 10
  • 10
  • 9
  • 8
  • 7
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

29
122
137
288

PUBLISHED

7
35
80
288

PRODUCT TYPE

255
31
2

Search "Dong-A Pharmaceutical Company Limited" returned 288 results.

Dong Kook Pharmaceutical Company Limited Acquisition Manual Dong Kook Pharmaceutical Company Limited Acquisition Manual - Product Thumbnail Image

Dong Kook Pharmaceutical Company Limited Acquisition Manual

The Acquisition Manual on Dong Kook Pharmaceutical Company Limited is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all...

July 2015

Dong-A Socio Holdings Co. Ltd. (000640) - Financial and Strategic SWOT Analysis Review

Dong-A Socio Holdings Co. Ltd. (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

June 2015
FROM

Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010

In 2008, the sales of Chinese pharmaceutical industry amounted to RMB 677 776 billion, rising by over 20% YOY Among the sub-industries, the sales growth rate of the biological product industry was 31...

December 2009
FROM

Dong-A Pharmaceutical Co., Ltd. (000640) - Financial and Strategic SWOT Analysis Review

Summary Dong-A Pharmaceutical Co., Ltd (Dong-A) is a research-based pharmaceutical and healthcare company. It focuses on the research and development in various therapeutic areas, including, metabolic/endocrine...

March 2013
FROM

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model...

February 2015
FROM

Asia-Pacific Pharmaceutical Market Analysis, 2010-2014

Having displayed quite healthy growth rates in the years 2005-2009 the Asia-Pacific pharmaceuticals market is expected to decelerate significantly in 2010 followed by the slow increase in growth in...

August 2010
FROM

Il Dong Pharmaceutical Company Limited

A textual analysis of the financial results for Il Dong Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

June 2015
FROM

Kwang Dong Pharmaceutical Company Limited

A textual analysis of the financial results for Kwang Dong Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

June 2015
FROM

Dong Wha Pharm Company Limited

A textual analysis of the financial results for Dong Wha Pharm Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

June 2015
FROM

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Diabetes - Pipeline Review, H2 2013

Diabetes - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

South Korea Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The domestic pharmaceutical industry will continue to have conflicts with the South Korean government over price controls. As a result of these price controls, growth of the pharmaceutical...

January 2015

China Dietary Supplement Industry Report, 2011-2012

In recent years, the dietary supplement industry has entered a new golden development stage in China, with the market size hitting RMB105 billion in 2011 and presenting a CAGR of 11 4% or so during...

May 2012
FROM

South Korea Pharmaceutical Market Analysis, 2010-2014

Having displayed fluctuating growth rates in the years 2005-2009 the South Korea pharmaceuticals market is expected to stabilize from 2010, showing slight deceleration in growth over the years up to...

August 2010
FROM

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used...

September 2013
FROM

Gastric Cancer - Pipeline Review, H1 2015

Gastric Cancer - Pipeline Review, H1 2015 Summary: This, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides...

March 2015
FROM

Type 2 Diabetes - Pipeline Review, H2 2013

Type 2 Diabetes - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Type 2 Diabetes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Dong-A Socio Holdings Co Ltd

A textual analysis of the financial results for Dong-A Socio Holdings Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

May 2015
FROM
Loading Indicator

Our Clients

Hewlett-Packard Company Microsoft Corporation Philips N.V. SONY Corporation Cypress Semiconductor Corporation Panasonic Corporation